Active ingredientNarazaciclibCat. No. P-N023-001CAS 1357470-29-1Family · Pharmaceutical analytical standards
Narazaciclib
An experimental multi-kinase inhibitor, active mainly on the CDK4 and CDK6 kinases that regulate the cell cycle, but also on NUAK1/ARK5 and CSF1R: it has been studied against cancer in phase 1 trials run in the US and China. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is described as able to cross the blood-brain barrier: it accumulates at high levels in the brain and in brain tumours, and in the laboratory it slows the proliferation of U87 glioma cells.
Go to the active ingredient →Active ingredientNarazaciclibCat. No. P-N023-001CAS 1357470-29-1
Isotopically labelledDesmethyl Narazaciclib-d8Cat. No. P-N023-002
ImpurityDesmethyl NarazaciclibCat. No. P-N023-005CAS 2419274-38-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.